Building on the success of our 2016 congress, Global Engage is pleased to announce the 2nd Probiotics Congress: Asia, which will be held on March 1-2 in Hong Kong and co-located with our 3rd Microbiome R&D and Business Collaboration Congress: Asia. Last year’s successful event attracted over 200 attendees.
An increasing awareness of the importance of the role different bacterial ecosystems play with regards to human health has led to a surge in research, publications and companies in the microbiome and probiotic space. As changes in our lifestyle and the growth of multi-drug resistant bacterial strains have also increased the need for better solutions and management of chronic and life-threatening illnesses, microbiome and probiotic research is one of the most scientifically important and potentially lucrative avenues to be exploring. There is mounting evidence that selected probiotic strains can confer health benefits to us, especially with regards to digestive diseases and pediatric health. Further research into mechanisms of action for particular strains, large-cohort clinical trials, and compliance with good manufacturing practice and standards will result in the next generation of probiotic products to ultimately advance both patient and animal care.